Patent · US Active

Antibodies that bind to EphA2 and methods of use thereof

US7776328B2 · kind B2 · utility

2Cited by

1References

28Claims

0Family size

Assignee

Macrogenics, Inc. · US

Inventors

Jennie P. Mather · Millbrae, US
Penelope E. Roberts · Millbrae, US

Key dates

Filing date	Jun 30, 2009
Grant date	Aug 17, 2010
Priority date	—
Expiry date	Jun 30, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/77
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein is disclosure about the development and characterization of an antibody that binds to antigen EphA2 which is present on a variety of human cancers from breast, lung, prostate, and colons. Methods of diagnosing and treating various cancers by using such antibodies directed against this antigen are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.